We are live on ! Find out more
EP

Elkhorn Partners Portfolio holdings

AUM $157M
1-Year Est. Return 11.91%
This Fund
S&P 500
This Quarter Est. Return
-1.56%
1 Year Est. Return
+11.91%
3 Year Est. Return
+31.51%
5 Year Est. Return
+35.62%
10 Year Est. Return
+87.18%
AUM
$153M
AUM Growth
-$3.69M
Cap. Flow
+$234K
Cap. Flow %
0.15%
Top 10 Hldgs %
95.61%
Holding
57
New
8
Increased
11
Reduced
18
Closed
6

Top Buys

Rank Stock Value
1
CDZI icon
Cadiz
CDZI
+$973K
2
BA icon
Boeing
BA
+$164K
3
MRNA icon
Moderna
MRNA
+$98.2K
4
GILD icon
Gilead Sciences
GILD
+$69.2K
5
HTZ icon
Hertz
HTZ
+$66.9K

Sector Composition

Rank Sector Weight
1 Financials 48.7%
2 Real Estate 40.71%
3 Communication Services 3.97%
4 Technology 1.7%
5 Materials 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAX icon
26
MediaAlpha
MAX
$746M
$128K 0.08%
15,500
-2,500
-14% -$22.3K
MRNA icon
27
Moderna
MRNA
$21.6B
$122K 0.08%
1,180
+880
+293% +$98.2K
ACTG icon
28
Acacia Research
ACTG
$437M
$117K 0.08%
32,100
-200
-0.6% -$765
BAC icon
29
Bank of America
BAC
$429B
$99K 0.06%
3,600
RDI icon
30
Reading International Class A
RDI
$32.5M
$90K 0.06%
42,500
KMI icon
31
Kinder Morgan
KMI
$70.9B
$86K 0.06%
5,200
VXX icon
32
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$169M
$82K 0.05%
875
JBLU icon
33
JetBlue
JBLU
$2.16B
$75K 0.05%
16,200
-2,400
-13% -$15.8K
UAL icon
34
United Airlines
UAL
$38.8B
$68K 0.04%
1,610
+60
+4% +$3.03K
GILD icon
35
Gilead Sciences
GILD
$165B
$67K 0.04%
+900
New +$69.2K
NEPH icon
36
Nephros
NEPH
$35.2M
$67K 0.04%
45,341
CRDF icon
37
Cardiff Oncology
CRDF
$63M
$63K 0.04%
45,000
-2,000
-4% -$3.37K
NWLI
38
DELISTED
National Western Life Group, Inc. Class A
NWLI
$61K 0.04%
140
-19
-12% -$8.35K
TGT icon
39
Target
TGT
$66.3B
$53K 0.03%
+480
New +$60.9K
FPH icon
40
Five Point Holdings
FPH
$387M
$50K 0.03%
17,000
HTZ icon
41
Hertz
HTZ
$527M
$49K 0.03%
+4,000
New +$66.9K
AMN icon
42
AMN Healthcare
AMN
$1.35B
$47K 0.03%
+550
New +$52.2K
NDAQ icon
43
Nasdaq
NDAQ
$53.4B
$47K 0.03%
975
-525
-35% -$26.6K
SCHW
44
Charles Schwab
SCHW
$182B
$30K 0.02%
550
-470
-46% -$28.4K
CRSP icon
45
CRISPR Therapeutics
CRSP
$4.69B
$11K 0.01%
250
+220
+733% +$11.4K
NVDA icon
46
NVIDIA
NVDA
$4.6T
$10K 0.01%
+220
New +$9.86K
TOST icon
47
Toast
TOST
$18.9B
$7K ﹤0.01%
+400
New +$8.68K
AMZN icon
48
Amazon
AMZN
$2.44T
$5K ﹤0.01%
40
-95
-70% -$12.7K
SOFI icon
49
CALL
SoFi Technologies
SOFI
$19.6B
$2K ﹤0.01%
+200
New +$1.76K
BMBL icon
50
Bumble
BMBL
$387M
-2,300
Closed -$39K

Similar funds

Elkhorn Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Elkhorn Partners held 57 positions worth $153M, down 2.4% from $157M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Elkhorn Partners's Q3 2023 filing shows 8 new, 11 increased, 18 reduced and 6 closed positions. Its largest new stake was Gilead Sciences: 900 shares worth $67K. The largest sale was White Mountains Insurance, an estimated $392K.

By sector, the portfolio is most concentrated in Financials at 49% of assets, up from 46% a quarter earlier, followed by Real Estate and Communication Services.

  • Elkhorn Partners's largest Q3 2023 buy was Gilead Sciences: 900 shares worth $67K.
  • Elkhorn Partners added most to Cadiz in Q3 2023, an estimated $973K increase.
  • Elkhorn Partners's biggest Q3 2023 reduction was White Mountains Insurance, cutting an estimated $392K.
  • Elkhorn Partners fully exited SoFi Technologies in Q3 2023, selling an estimated $141K.
  • Elkhorn Partners's ten largest holdings make up 96% of its $153M portfolio in Q3 2023.
  • Elkhorn Partners opened 8 new positions and closed 6 in Q3 2023.
  • Elkhorn Partners's portfolio value fell 2.4% quarter-over-quarter to $153M.

Based on Elkhorn Partners's 13F filing for Q3 2023, filed 13 Nov 2023.